These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7678166)

  • 21. Aspects of database construction and interrogation of relevance to the accurate prediction of rodent carcinogenicity and mutagenicity.
    Ashby J
    Environ Health Perspect; 1991 Dec; 96():97-100. PubMed ID: 1820286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guide for the Salmonella typhimurium/mammalian microsome tests for bacterial mutagenicity.
    Claxton LD; Allen J; Auletta A; Mortelmans K; Nestmann E; Zeiger E
    Mutat Res; 1987 Oct; 189(2):83-91. PubMed ID: 3309640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance.
    Zeiger E
    Regul Toxicol Pharmacol; 1998 Oct; 28(2):85-95. PubMed ID: 9927558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated decision-tree testing strategies for mutagenicity and carcinogenicity with respect to the requirements of the EU REACH legislation.
    Combes R; Grindon C; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():43-63. PubMed ID: 19025331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International prevalidation study on cell transformation assay. Preface.
    Corvi R; Vanparys P
    Mutat Res; 2012 Apr; 744(1):1-2. PubMed ID: 22387843
    [No Abstract]   [Full Text] [Related]  

  • 26. Guide for performing the mouse lymphoma assay for mammalian cell mutagenicity.
    Clive D; Caspary W; Kirby PE; Krehl R; Moore M; Mayo J; Oberly TJ
    Mutat Res; 1987 Oct; 189(2):143-56. PubMed ID: 3657830
    [No Abstract]   [Full Text] [Related]  

  • 27. Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests.
    Kim BS; Margolin BH
    Environ Mol Mutagen; 1999; 34(4):297-304. PubMed ID: 10618179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ability of short-term tests to predict carcinogenesis in rodents.
    Mason JM; Langenbach R; Shelby MD; Zeiger E; Tennant RW
    Annu Rev Pharmacol Toxicol; 1990; 30():149-68. PubMed ID: 2188566
    [No Abstract]   [Full Text] [Related]  

  • 29. Application of a cellular test battery in the decision point approach to carcinogen identification.
    Williams GM; Weisburger JH
    Mutat Res; 1988; 205(1-4):79-90. PubMed ID: 3285200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Employing an adverse outcome pathway framework for weight-of-evidence assessment with application to the ICH S1B guidance addendum.
    Stalford SA; Cayley AN; de Oliveira AAF
    Regul Toxicol Pharmacol; 2021 Dec; 127():105071. PubMed ID: 34737134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of the predictivity of some short-term assays for carcinogenicity in rodents.
    Klopman G; Rosenkranz HS
    Mutat Res; 1991 Dec; 253(3):237-40. PubMed ID: 1720198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analysis by chemical class of Salmonella mutagenicity tests as predictors of animal carcinogenicity.
    Claxton LD; Stead AG; Walsh D
    Mutat Res; 1988; 205(1-4):197-225. PubMed ID: 3285187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity.
    Dearfield KL; Auletta AE; Cimino MC; Moore MM
    Mutat Res; 1991 Nov; 258(3):259-83. PubMed ID: 1719404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of a novel molecular orbital approach (COMPACT) for the prospective safety evaluation of chemicals, by comparison with rodent carcinogenicity and Salmonella mutagenicity data evaluated by the U.S. NCI/NTP.
    Lewis DF; Ioannides C; Parke DV
    Mutat Res; 1993 Feb; 291(1):61-77. PubMed ID: 7678916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An association between mutagenicity of the Ara test of Salmonella typhimurium and carcinogenicity in rodents for 16 halogenated aliphatic hydrocarbons.
    Roldán-Arjona T; García-Pedrajas MD; Luque-Romero FL; Hera C; Pueyo C
    Mutagenesis; 1991 May; 6(3):199-205. PubMed ID: 1881351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A guide for performing germ cell mutagenesis assays using Drosophila melanogaster.
    Mason JM; Aaron CS; Lee WR; Smith PD; Thakar A; Valencia R; Woodruff RC; Würgler FE; Zimmering S
    Mutat Res; 1987 Oct; 189(2):93-102. PubMed ID: 3116424
    [No Abstract]   [Full Text] [Related]  

  • 37. Carcinogen testing. Fact and fallacy.
    Moore JA
    Cancer; 1988 Oct; 62(8 Suppl):1688-90. PubMed ID: 3167787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integration of structure-activity relationship and artificial intelligence systems to improve in silico prediction of ames test mutagenicity.
    Mazzatorta P; Tran LA; Schilter B; Grigorov M
    J Chem Inf Model; 2007; 47(1):34-8. PubMed ID: 17238246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The challenge of testing chemicals for potential carcinogenicity using multiple short-term assays: an analysis of a proposed test battery for hair dyes.
    Rosenkranz HS; Cunningham SL; Mermelstein R; Cunningham AR
    Mutat Res; 2007 Sep; 633(1):55-66. PubMed ID: 17625954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro carcinogenicity testing: present and future perspectives in pharmaceutical development.
    Kowalski LA
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):29-35. PubMed ID: 11727320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.